Heritage Way Advisors’s Novartis NVS Stock Holding History

Heritage Way Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$3.11M	Buy	35,585 +453	+1%	+$37.6K	1.17%	32
2021 Q3	$2.87M	Sell	35,132 -165	-0.5%	-$14.8K	1.19%	33
2021 Q2	$3.22M	Sell	35,297 -854	-2%	-$76K	1.32%	28
2021 Q1	$3.09M	Sell	36,151 -610	-2%	-$54.7K	1.35%	31
2020 Q4	$3.47M	Sell	36,761 -1,162	-3%	-$102K	1.6%	21
2020 Q3	$3.3M	Buy	37,923 +1,257	+3%	+$109K	1.73%	14
2020 Q2	$3.2M	Buy	36,666 +1,964	+6%	+$170K	1.87%	12
2020 Q1	$2.86M	Buy	34,702 +1,093	+3%	+$97.5K	2.06%	7
2019 Q4	$3.18M	Buy	33,609 +386	+1%	+$34.6K	1.84%	15
2019 Q3	$2.89M	Buy	33,223 +1,978	+6%	+$178K	1.83%	15
2019 Q2	$2.85M	Sell	31,245 -3,162	-9%	-$268K	1.82%	17
2019 Q1	$2.96M	Sell	34,407 -352	-1%	-$28.3K	1.99%	12
2018 Q4	$2.67M	Buy	34,759 +354	+1%	+$27.6K	2.05%	12
2018 Q3	$2.66M	Buy	34,405 +614	+2%	+$45.4K	1.84%	18
2018 Q2	$2.29M	Buy	33,791 +1,060	+3%	+$73.1K	1.68%	25
2018 Q1	$2.37M	Buy	32,731 +390	+1%	+$29.7K	1.84%	21
2017 Q4	$2.43M	Buy	32,341 +1,535	+5%	+$116K	1.83%	17
2017 Q3	$2.37M	Buy	30,806 +670	+2%	+$50.6K	1.94%	12
2017 Q2	$2.25M	Buy	30,136 +1,589	+6%	+$113K	1.92%	9
2017 Q1	$1.9M	Buy	28,547 +1,339	+5%	+$89.2K	1.75%	24
2016 Q4	$1.78M	Buy	+27,208	New	+$1.76M	1.75%	25

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Heritage Way Advisors's NVS Position: Q4 2021 in Review

Heritage Way Advisors increased its Novartis (NVS) stake by 1.3% in Q4 2021, buying an estimated $37.6K and bringing the position to 35,585 shares worth $3.11M. The position accounts for 1.17% of the portfolio, ranked #32.

Heritage Way Advisors first reported a position in NVS in Q4 2016 and has held it in 21 quarters since. The position peaked at $3.47M in Q4 2020. 1,147 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

Heritage Way Advisors held 35,585 shares of Novartis worth $3.11M as of Q4 2021.
Heritage Way Advisors bought 453 Novartis shares in Q4 2021, an estimated $37.6K.
Novartis made up 1.17% of Heritage Way Advisors's portfolio in Q4 2021, its #32 holding.
Heritage Way Advisors first reported a position in Novartis in Q4 2016 and has held it in 21 quarters since.
Heritage Way Advisors's Novartis position peaked at $3.47M in Q4 2020.
1,147 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Heritage Way Advisors's 13F filing for Q4 2021, filed 13 Jan 2022.